title: Liposomal cytarabine in central nervous system disease of haematological malignancies: more effective but more toxic?
authors.forename: M
authors.initials: M
authors.lastname: Tormo Díaz
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology* / Q000633:toxicity; D002490:Central Nervous System / Q000378:metabolism*; D002493:Central Nervous System Diseases / Q000150:complications* / Q000188:drug therapy*; D002648:Child; D003561:Cytarabine / Q000494:pharmacology* / Q000633:toxicity; D019337:Hematologic Neoplasms / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008081:Liposomes / Q000737:chemistry*; D008495:Medical Oncology / Q000379:methods; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D013030:Spain; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D008081:Liposomes; D003561:Cytarabine